"How Many Patients Could Benefit From Pre-emptive Pharmacogenomic Testing ..."

Wolfgang Kuch et al. (2016)

> Home

Details and statistics

DOI: 10.3233/978-1-61499-645-3-253

access: closed

type: Conference or Workshop Paper

metadata version: 2021-04-09

- view
  - electronic edition via DOI
  - unpaywalled version
  authority control:
- export record
  dblp key:
  - conf/ehealth2/KuchRGS16
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/conf/ehealth2/KuchRGS16
Wolfgang Kuch, Christoph Rinner, Walter Gall, Matthias Samwald:
How Many Patients Could Benefit From Pre-emptive Pharmacogenomic Testing and Decision Support? A Retrospective Study Based on Nationwide Austrian Claims Data. eHealth 2016: 253-258

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.